2000: born in Turin to create and develop formulas to prevent metabolic diseases often due to metabolic malfunctions. All formulations have been absolute innovations on the Italian pharmaceutical market.

2000: Biohealth puts on the market the first Italian potassium and magnesium citrate based granular product, internationally renowned as an excellent choice for treating calcic and uratic nephrolithiasis.

2001: Biohealth introduces to the market the first Italian neutral potassium phosphate supplement, which is considered by international literature to be an excellent drug for treating hypophosphatemic hypercalciuric tubulopathies, and other forms of hypercalciuria.